Hitachi selects Agilent Technologies' microarrays for pharmaceutical research
PALO ALTO, Calif., July 25, 2002 - Agilent Technologies Inc. today announced an agreement with Hitachi Ltd. life science Group of Japan for the supply of Agilent's custom and catalog microarrays, a microarray reader and consumables to aid scientists in the search for disease-related genes, used in pharmaceutical research. The microarrays will be used by Hitachi in a new contract research service center to be opened later this month, for those Japanese pharmaceutical companies wishing to do gene expression research into human diseases.
"We are pleased that Hitachi has selected Agilent for the supply of microarrays for its contract gene expression research in Japan," said Chris van Ingen, senior vice president of Agilent's Life Sciences and Chemical Analysis business. "We look forward to enabling Hitachi to generate gene expression information that will be used to identify causes of human diseases and the cures for those diseases."
Hitachi will use Agilent's catalog human, mouse and rat microarrays as well as custom designed microarrays. Until now, Hitachi has been using in-house developed microarrays for its research purposes. With the new service, Hitachi intends to attract those researchers who wish to do a wide range of research using a large number of gene and drug candidates.
Most read news
Topics
Organizations
Other news from the department research and development

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

21.4% record efficiency for flexible solar cells - Flexible solar cells gain power

Ionic liquids make a splash in next-gen solid-state lithium metal batteries - Quasi-solid-state-electrodes realize a significant reduction in interfacial resistance
